Sign in

CIK 0001754068 · Non-accelerated filer<br>Smaller reporting company

Kalaris Therapeutics, Inc.

Sign in to watch
Ticker
KLRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
831971007
Phone
650-249-2727
Business address
400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
Former names
Allovir, Inc., ViraCyte, Inc.
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. CERT Other Certification
  4. 8-A12B/A Other Registration Statement
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. 8-A12B Other Registration of Securities
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. UPLOAD Other SEC-generated Letter
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. S-1/A Offering Registration Statement
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. UPLOAD Other SEC-generated Letter
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. S-1 Offering Registration Statement
  18. UPLOAD Other SEC-generated Letter
  19. DRS Other Draft Registration Statement
  20. D Other Notice of Sales of Unregistered Securities

Page 35 of 36 · 701 filings